Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity
使用 CDK4/6 抑制剂 palbociclib 靶向癌症干细胞增殖：端粒酶驱动肿瘤细胞异质性
期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.14196
Gloria Bonuccelli, Maria Peiris-Pages, Bela Ozsvari, Ubaldo E Martinez-Outschoorn, Federica Sotgia, Michael P Lisanti
